Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
Tobler LH, Stramer SL, Lee SR, Masecar BL, Peterson JE, Davis EA, Andrews WE, Brodsky JP, Kleinman SH, Phelps BH, Busch MP.
Tobler LH, et al. Among authors: phelps bh.
Transfusion. 2003 Oct;43(10):1452-9. doi: 10.1046/j.1537-2995.2003.00521.x.
Transfusion. 2003.
PMID: 14507279